Cut through the noise around GLP-1s
Employers, health plans, and their partners are considering various management strategies to get a handle on obesity and curb cost trends. Some hope that new GLP-1 medications can solve the obesity crisis; others want to shut off access to the drugs completely.
As new information comes out about how best to treat obesity, it can be hard to get to the bottom of what really matters for outcomes — and costs. Read our guide to learn:
- 5 common myths of obesity management
- Which numbers carry the most weight for good health
- How obesity step therapy curbs costs
- Why personalized care is essential for diverse populations